TINAVI(SH:688277) Xin Lang Cai Jing·2026-01-20 02:47Core Viewpoint - Tianzhihang's stock price has shown significant volatility, with a year-to-date increase of 44.37%, but a recent decline of 2.01% on January 20, 2025, indicating potential market fluctuations and investor sentiment shifts [1]. Group 1: Company Overview - Tianzhihang Medical Technology Co., Ltd. is located in Haidian District, Beijing, and was established on October 22, 2010, with its IPO on July 7, 2020 [1]. - The company's main business focuses on the research, production, sales, and service of orthopedic surgical navigation robots, with revenue composition as follows: 58.31% from orthopedic surgical navigation robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1]. Group 2: Financial Performance - For the period from January to September 2025, Tianzhihang achieved operating revenue of 187 million yuan, representing a year-on-year growth of 103.51%, while the net profit attributable to shareholders was -114 million yuan, a decrease of 49.73% year-on-year [2]. - As of September 30, 2025, the number of shareholders increased by 12.31% to 17,300, with an average of 26,094 circulating shares per person, a decrease of 10.96% [2]. Group 3: Market Activity - On January 20, 2025, Tianzhihang's stock experienced a trading volume of 78.62 million yuan, with a turnover rate of 0.77% and a total market capitalization of 10 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on January 14, 2025 [1]. - Institutional holdings as of September 30, 2025, show that E Fund's National Robot Industry ETF is the sixth largest circulating shareholder with 10.78 million shares, while Huaxia's CSI Robot ETF is the eighth largest with 8.72 million shares, an increase of 1.63 million shares from the previous period [2].